How can medical device companies improve the sustainability of clinical products?

Costa Rican Investment Promotion Agency. CINDE contributes to the country’s economic and sustainable development, its economic impact and its social progress.

Dec 20, 2024 · As another year draws to a close, we look at the most consequential stories and emergent themes of the year in the medical device space, from challenges surrounding cybersecurity and device recalls, to M&A activity and what Donald Trump’s return to the White House could mean for the industry.

Dec 18, 2024 · The future of the medical devices: Trends for 2025 and beyond. Advancements in artificial intelligence, precision medicine, and digital health pave the way for innovation that enhances patient care, improves efficiency, and addresses …

Jun 15, 2023 · The device is only available in the US so far, but Cala is hoping to expand globally in the future. According to GlobalData, the global wearable technology market is expected to register a compound annual growth rate of 19% from $22bn in 2018 to $54.4bn in 2023.. Cala founder and chief scientific officer Kate Rosenbluth spoke to Medical Device Network about the future for Cala: “While being ...

China bans Illumina sequencer imports as US trade war intensifies. China has banned the import of Illumina’s next-generation sequencing (NGS) sequencers as part of retaliatory measures against fresh tariffs imposed…

The Medical Device Network Excellence Awards winners have been announced! Download our full 60+ page report to find out more

Mar 1, 2024 · The FDA approved Butterfly iQ3, a next-generation handheld point-of-care ultrasound system (POCUS), in January 2024. It is the third version of the world’s first semiconductor-based single-probe, whole-body ultrasound system Butterfly iQ.

The leading site for news and procurement in the medical device industry

Feb 3, 2025 · Positive top line data came courtesy of RELIVE, the company’s multi-reader multi-case (MRMC) study of a 480-patient cohort, which aimed to demonstrate that eyonis was capable of improving clinicians’ diagnostic accuracy in the analysis of LDCT scans.